Shilpa Gupta, MD: Clinical Trials

1 recruiting. 1 Phase 1.

By phase and status

Phase	Trials	Status
Phase 1	1	Recruiting 1

Follow Shilpa Gupta, MD: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Adaptive RADiation Therapy With Concurrent Sacituzumab Govitecan (SG) for Muscle Invasive Bladder Cancer Sacituzumab govitecan, Adaptive Radiotherapy - Localized Muscle Invasive Bladder Urothelial Carcinoma, Muscle-Invasive Bladder Carcinoma	Phase 1	Recruiting	Shilpa Gupta, MD	20	2024-04-01	2026-07-20

Interventions

sacituzumab govitecan (1)

Countries

United States (1)